España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Trevi Therapeutics
TRVI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Trevi Therapeutics (TRVI) Forecast
News
Earnings
Trevi Therapeutics (TRVI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Trevi Therapeutics (NASDAQ:TRVI) Stock
Trevi Therapeutics Stock (NASDAQ: TRVI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Thursday, November 07, 2024
EF Hutton Maintains Buy on Trevi Therapeutics...
Benzinga Newsdesk
Wednesday, November 06, 2024
Trevi Therapeutics Q3 2024 GAAP EPS $(0.13) M...
Benzinga Newsdesk
Tuesday, October 22, 2024
HC Wainwright & Co. Reiterates Buy on Trevi T...
Benzinga Newsdesk
Monday, October 21, 2024
EF Hutton Maintains Buy on Trevi Therapeutics...
Benzinga Newsdesk
Trevi Therapeutics Completes Enrollment In Th...
Benzinga Newsdesk
Monday, October 07, 2024
B. Riley Securities Reiterates Buy on Trevi T...
Benzinga Newsdesk
Friday, October 04, 2024
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
EF Hutton Maintains Buy on Trevi Therapeutics...
Benzinga Newsdesk
Thursday, October 03, 2024
Trevi Therapeutics Provides Update on Haduvio...
Benzinga Newsdesk
Thursday, September 26, 2024
Trevi Therapeutics Announced That Data From T...
Benzinga Newsdesk
Tuesday, September 17, 2024
EF Hutton Maintains Buy on Trevi Therapeutics...
Benzinga Newsdesk
Wednesday, September 04, 2024
Trevi Therapeutics To Present Data From Ph2a ...
Benzinga Newsdesk
Friday, August 30, 2024
HC Wainwright & Co. Initiates Coverage On Tre...
Benzinga Newsdesk
Raymond James Initiates Coverage On Trevi The...
Benzinga Newsdesk
Monday, August 19, 2024
EF Hutton Initiates Coverage On Trevi Therape...
Benzinga Newsdesk
Thursday, August 08, 2024
Trevi Therapeutics Q2 2024 GAAP EPS $(0.12) M...
Benzinga Newsdesk
Thursday, June 13, 2024
Rodman & Renshaw Initiates Coverage On Trevi ...
Benzinga Newsdesk
Thursday, June 06, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, May 08, 2024
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Tuesday, May 07, 2024
Trevi Therapeutics shares are trading lower a...
Benzinga Newsdesk
Trevi Therapeutics Q1 2024 GAAP EPS $(0.11) M...
Benzinga Newsdesk
Tuesday, April 09, 2024
Trevi Therapeutics to Present Phase 2 Results...
Benzinga Newsdesk
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Thursday, March 21, 2024
Oppenheimer Maintains Outperform on Trevi The...
Benzinga Newsdesk
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Wednesday, March 20, 2024
Trevi Therapeutics: Q4 Earnings Insights
Benzinga Insights
Trevi Therapeutics Q4 2023 GAAP EPS $(0.08) B...
Benzinga Newsdesk
Earnings Scheduled For March 20, 2024
Benzinga Insights
Tuesday, March 19, 2024
Earnings Outlook For Trevi Therapeutics
Benzinga Insights
Thursday, January 04, 2024
Trevi Therapeutics Gears Up for Data-Rich Yea...
Benzinga Newsdesk
Tuesday, December 05, 2023
Trevi Therapeutics Announces the Initiation o...
Benzinga Newsdesk
Thursday, November 09, 2023
Trevi Therapeutics Q3 2023 Gaap EPS $(0.08) B...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
Trevi Therapeutics's Earnings: A Preview
Benzinga Insights
Thursday, November 02, 2023
Trevi Therapeutics Has Initiated Its Phase 2A...
Benzinga Newsdesk
Friday, October 13, 2023
Trevi Therapeutics Announces Results From Pha...
Benzinga Newsdesk
Friday, August 11, 2023
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Thursday, August 10, 2023
Trevi Therapeutics Q2 EPS $(0.07) Beats $(0.0...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Tuesday, August 01, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, June 29, 2023
Trevi Therapeutics Filed For Mixed Shelf Of Up To $200M
Charles Gross
Monday, May 22, 2023
Trevi Therapeutics Announces Publication Of D...
Benzinga Newsdesk
Friday, May 12, 2023
Needham Reiterates Buy on Trevi Therapeutics,...
Benzinga Newsdesk
Thursday, May 11, 2023
Recap: Trevi Therapeutics Q1 Earnings
Benzinga Insights
Trevi Therapeutics Q1 EPS $(0.06) Beats $(0.0...
Benzinga Newsdesk
Earnings Scheduled For May 11, 2023
Benzinga Insights
Wednesday, May 10, 2023
Earnings Preview: Trevi Therapeutics
Benzinga Insights
Tuesday, April 18, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
